ப்ரோடீந் சிக்கலான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரோடீந் சிக்கலான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரோடீந் சிக்கலான Today - Breaking & Trending Today

ImmunoMet Therapeutics Granted Fast Track Designation by U.S. FDA for IM156 in Idiopathic Pulmonary


Search jobs
ImmunoMet Therapeutics Granted Fast Track Designation by U.S. FDA for IM156 in Idiopathic Pulmonary Fibrosis
HOUSTON (BUSINESS WIRE) ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead compound IM156, an investigational Protein Complex 1 (PC1) inhibitor, being evaluated for idiopathic pulmonary fibrosis (IPF).
“Fast Track designation is another important milestone for ImmunoMet with the potential to speed our ability to advance IM156 to patients,” commented Benjamin Cowen, Chief Executive Officer of ImmunoMet Therapeutics. “Additionally, we are pleased with the progress we are making in the ongoing U.S. Phase 1 study in healthy volunteers.” ....

United States , Benjamin Cowen , Immunomet Therapeutics Inc , Drug Administration , Immunomet Therapeutics , Fast Track , Protein Complex , Chief Executive Officer , ஒன்றுபட்டது மாநிலங்களில் , பெஞ்சமின் கோவன் , வேகமாக டிராக் , ப்ரோடீந் சிக்கலான , தலைமை நிர்வாகி அதிகாரி ,